{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:37:33Z","timestamp":1792892253686,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z191100006619056"],"award-info":[{"award-number":["Z191100006619056"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021A02303"],"award-info":[{"award-number":["CI2021A02303"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["ZZ15-XY-PT-15"],"award-info":[{"award-number":["ZZ15-XY-PT-15"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37624","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T04:47:25Z","timestamp":1725684445000},"page":"e37624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring shared mechanisms between ulcerative colitis and psoriasis and predicting therapeutic natural compounds through bioinformatics and molecular docking"],"prefix":"10.1016","volume":"10","author":[{"given":"Yixuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuozhi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8790-1383","authenticated-orcid":false,"given":"Bingnan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9853","key":"10.1016\/j.heliyon.2024.e37624_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"issue":"10281","key":"10.1016\/j.heliyon.2024.e37624_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37624_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis","volume":"154","author":"Fu","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37624_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/ecco-jcc\/jjz152","article-title":"Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease-A systematic review and meta-analysis","volume":"14","author":"Alinaghi","year":"2020","journal-title":"Journal of Crohn's & colitis"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajhg.2012.02.020","article-title":"Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci","volume":"90","author":"Ellinghaus","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37624_bib6","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gut.2008.163667","article-title":"Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease","volume":"58","author":"Brand","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib7","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1038\/s41598-019-43899-9","article-title":"Th1, Th17, and Treg responses are differently modulated by TNF-\u03b1 inhibitors and Methotrexate in psoriasis patients","volume":"9","author":"Furiati","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37624_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00403-017-1750-3","article-title":"The role of microbiota, and probiotics and prebiotics in skin health","volume":"309","author":"Maguire","year":"2017","journal-title":"Arch. Dermatol. Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37624_bib9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/bies.201600008","article-title":"The gut-skin axis in health and disease: a paradigm with therapeutic implications","volume":"38","author":"O'Neill","year":"2016","journal-title":"Bioessays"},{"key":"10.1016\/j.heliyon.2024.e37624_bib10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3389\/fmicb.2018.01459","article-title":"The gut microbiome as a major regulator of the gut-skin Axis","volume":"9","author":"Salem","year":"2018","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jid.2018.07.029","article-title":"Incidence and risk of inflammatory bowel disease in patients with psoriasis-A nationwide 20-year cohort study","volume":"139","author":"Egeberg","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib12","first-page":"257","article-title":"Is psoriasis treatment a risk factor for inflammatory bowel disease?","volume":"34","author":"Nehring","year":"2020","journal-title":"Pharmaceut. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jmg.2007.053595","article-title":"Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease","volume":"45","author":"Wolf","year":"2008","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","article-title":"Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis","volume":"122","author":"Capon","year":"2007","journal-title":"Hum. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"5804","key":"10.1016\/j.heliyon.2024.e37624_bib16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaad.2017.06.043","article-title":"Management of psoriasis in patients with inflammatory bowel disease: from the medical board of the national psoriasis foundation","volume":"78","author":"Whitlock","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37624_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nri2778","article-title":"Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria","volume":"10","author":"Varol","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37624_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmed.2009.03.002","article-title":"CD4 T-cell differentiation and inflammatory bowel disease","volume":"15","author":"Zenewicz","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37624_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/eji.201444972","article-title":"The role of the microbiota in inflammation, carcinogenesis, and cancer therapy","volume":"45","author":"Dzutsev","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ibd.21339","article-title":"Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases","volume":"17","author":"Frank","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37624_bib25","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/jid.2011.182","article-title":"Microbial symbiosis with the innate immune defense system of the skin","volume":"131","author":"Gallo","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13317-013-0057-4","article-title":"The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications","volume":"5","author":"Marinoni","year":"2014","journal-title":"Auto- immunity highlights"},{"key":"10.1016\/j.heliyon.2024.e37624_bib27","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2147\/DDDT.S319786","article-title":"Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua san against ulcerative colitis","volume":"15","author":"Liu","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41598-021-03980-8","article-title":"Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis","volume":"12","author":"Wu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e37624_bib29","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.2147\/DDDT.S375281","article-title":"Integrated metabonomics and network pharmacology to reveal the action mechanism effect of Shaoyao decoction on ulcerative colitis","volume":"16","author":"Wu","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37624_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/apt.12464","article-title":"Systematic review: the efficacy of herbal therapy in inflammatory bowel disease","volume":"38","author":"Ng","year":"2013","journal-title":"Aliment Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2036.2010.04515.x","article-title":"Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine","volume":"33","author":"Tang","year":"2011","journal-title":"Aliment Pharmacol. Therapeut."},{"issue":"39","key":"10.1016\/j.heliyon.2024.e37624_bib32","doi-asserted-by":"crossref","first-page":"14099","DOI":"10.3748\/wjg.v20.i39.14099","article-title":"Advances in treatment of ulcerative colitis with herbs: from bench to bedside","volume":"20","author":"Wan","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bjd.15894","article-title":"Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial","volume":"178","author":"Lin","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.heliyon.2024.e37624_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113306","article-title":"An integrated metabolism in vivo analysis and network pharmacology in UC rats reveal anti-ulcerative colitis effects from Sophora flavescens EtOAc extract","volume":"186","author":"Chen","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e37624_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2017.04.020","article-title":"Investigating the potential of Oxymatrine as a psoriasis therapy","volume":"271","author":"Chen","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.heliyon.2024.e37624_bib36","article-title":"Integrating pharmacology and microbial network analysis with experimental validation to reveal the mechanism of composite Sophora colon-soluble capsule against ulcerative colitis","volume":"2020","author":"Ding","year":"2020","journal-title":"Evid. base Compl. Alternative Med. : eCAM"},{"key":"10.1016\/j.heliyon.2024.e37624_bib37","first-page":"1","article-title":"Sophora flavescens containing-QYJD formula activates Nrf2 anti-oxidant response, blocks cellular transformation and protects against DSS-induced colitis in mouse model","author":"Fang","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib38","first-page":"172","article-title":"[A multi-center randomized double-blinded, placebo-controlled clinical study on efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis of internal dampness-heat accumulation syndrome type]","volume":"31","author":"Tong","year":"2011","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e37624_bib39","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1007\/s00018-016-2311-1","article-title":"Environmental factors in autoimmune diseases and their role in multiple sclerosis","volume":"73","author":"J\u00f6rg","year":"2016","journal-title":"Cell. Mol. Life Sci. : CM"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37624_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ecco-jcc\/jjad178","article-title":"Matrix metalloproteinases in intestinal fibrosis","volume":"18","author":"Biel","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.2008.03836.x","article-title":"Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium","volume":"155","author":"Pedersen","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37624_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9913798","article-title":"Assessment of selected matrix metalloproteinases (MMPs) and correlation with cytokines in psoriatic patients","volume":"2021","author":"Michalak-Stoma","year":"2021","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BOR.0000000000000358","article-title":"Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn?","volume":"29","author":"Alexander","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.advms.2015.07.011","article-title":"CXCL10 in psoriasis","volume":"60","author":"Ferrari","year":"2015","journal-title":"Adv. Med. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37624_bib45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/gut.30.6.835","article-title":"Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease","volume":"30","author":"Mahida","year":"1989","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/cyto.2002.1985","article-title":"The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues","volume":"20","author":"Kabashima","year":"2002","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37624_bib47","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1002\/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1","article-title":"Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival","volume":"32","author":"Sasaki","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9440(10)65128-0","article-title":"Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis","volume":"155","author":"Uguccioni","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib49","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.175.4.2721","article-title":"TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques","volume":"175","author":"Gottlieb","year":"2005","journal-title":"Journal of immunology (Baltimore, Md"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ibd.20339","article-title":"Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD","volume":"14","author":"Seiderer","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ibd.21677","article-title":"Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease","volume":"18","author":"Hundorfean","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37624_bib53","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"Journal of immunology (Baltimore, Md"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37624_bib54","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37624_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.MIB.0000218764.06959.91","article-title":"Critical role of IL-17 receptor signaling in acute TNBS-induced colitis","volume":"12","author":"Zhang","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib56","first-page":"278","article-title":"Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis","volume":"18","author":"Cheng","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"22","key":"10.1016\/j.heliyon.2024.e37624_bib57","first-page":"4275","article-title":"Bioinformatic analysis of potential candidates for therapy of inflammatory bowel disease","volume":"19","author":"Li","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37624_bib58","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0091270007301623","article-title":"The role of TNFalpha in ulcerative colitis","volume":"47","author":"Sands","year":"2007","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37624_bib59","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/hmg\/11.11.1281","article-title":"Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors","volume":"11","author":"van Heel","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000007470","article-title":"Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis","volume":"59","author":"Funakoshi","year":"1998","journal-title":"Digestion"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37624_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ph16091272","article-title":"Pharmacological therapy in inflammatory bowel diseases: a narrative review of the past 90 years","volume":"16","author":"Imbrizi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gendis.2020.02.004","article-title":"Therapeutic potential of TNF\u03b1 inhibitors in chronic inflammatory disorders: past and future","volume":"8","author":"Zhang","year":"2021","journal-title":"Genes & diseases"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37624_bib63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in chronic inflammation: from discovery to targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37624_bib65","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"Journal of immunology (Baltimore, Md"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib67","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/039463200902200411","article-title":"TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept","volume":"22","author":"Caldarola","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib68","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1993.tb03457.x","article-title":"Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor","volume":"94","author":"Kristensen","year":"1993","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37624_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jdermsci.2010.12.008","article-title":"Circulating microRNA associated with TNF-\u03b1 signaling pathway in patients with plaque psoriasis","volume":"61","author":"Oyama","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.heliyon.2024.e37624_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8717369","article-title":"Combined transcriptomic analysis revealed AKR1B10 played an important role in psoriasis through the dysregulated lipid pathway and overproliferation of keratinocyte","volume":"2017","author":"Gao","year":"2017","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37624_bib71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/path.4786","article-title":"Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes","volume":"240","author":"Leite Dantas","year":"2016","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37624_bib72","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1172\/JCI29441","article-title":"Misbehaving macrophages in the pathogenesis of psoriasis","volume":"116","author":"Clark","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e37624_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7215072","article-title":"Contribution of in vivo and organotypic 3D models to understanding the role of macrophages and neutrophils in the pathogenesis of psoriasis","volume":"2017","author":"Lorthois","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37624_bib74","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1172\/JCI27180","article-title":"Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib75","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2133.2010.10129.x","article-title":"Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice","volume":"164","author":"Ward","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.gastro.2005.05.013","article-title":"Characteristics of intestinal dendritic cells in inflammatory bowel diseases","volume":"129","author":"Hart","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2024.e37624_bib77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2014.00131","article-title":"Human dendritic cell functional specialization in steady-state and inflammation","volume":"5","author":"Boltjes","year":"2014","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/1346-8138.15184","article-title":"Dendritic cells: the driver of psoriasis","volume":"47","author":"Wang","year":"2020","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37624_bib79","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00018-020-03726-1","article-title":"Immune responses and therapeutic options in psoriasis","volume":"78","author":"Afonina","year":"2021","journal-title":"Cell. Mol. Life Sci. : CM"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/ped.2019.1137","article-title":"Quercetin improves inflammation, oxidative stress, and impaired wound healing in atopic dermatitis model of human keratinocytes","volume":"33","author":"Beken","year":"2020","journal-title":"Pediatric allergy, immunology, and pulmonology"},{"key":"10.1016\/j.heliyon.2024.e37624_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107557","article-title":"Inhibitory effect of quercetin on propionibacterium acnes-induced skin inflammation","volume":"96","author":"Lim","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/nu14010067","article-title":"Regulatory effects of quercetin on M1\/M2 macrophage polarization and oxidative\/antioxidative balance","volume":"14","author":"Tsai","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e37624_bib83","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","article-title":"Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway","volume":"48","author":"Chen","year":"2017","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2024.e37624_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154658","article-title":"Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: network pharmacology analysis and experimental evidence","volume":"111","author":"Duan","year":"2023","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"key":"10.1016\/j.heliyon.2024.e37624_bib85","article-title":"Luteolin attenuates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via suppression of inflammation response","volume":"131","author":"Zhou","year":"2020","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37624_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103057","article-title":"Citrus aurantium L. And its flavonoids regulate TNBS-induced inflammatory bowel disease through anti-inflammation and suppressing isolated jejunum contraction","volume":"19","author":"He","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.heliyon.2024.e37624_bib87","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1021\/acs.jafc.8b02524","volume":"66","author":"Yang","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2024.e37624_bib88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2019.12.012","article-title":"Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis","volume":"148","author":"Zhang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e37624_bib89","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.biopha.2018.10.062","article-title":"Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-\u03baB and TLR7 pathways in mice","volume":"109","author":"Li","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib90","first-page":"865","article-title":"Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis","volume":"31","author":"Gerges Geagea","year":"2017","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib91","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12906-016-1325-4","article-title":"Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Compl. Alternative Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1872211313666190503112040","article-title":"Nutraceuticals' novel formulations: the good, the bad, the unknown and patents involved","volume":"13","author":"Helal","year":"2019","journal-title":"Recent Pat. Drug Deliv. Formulation"},{"issue":"48","key":"10.1016\/j.heliyon.2024.e37624_bib93","doi-asserted-by":"crossref","first-page":"15189","DOI":"10.1021\/acs.jafc.2c06376","article-title":"Hydrolytic quinoa protein and cationic Lotus root starch-based micelles for Co-delivery of quercetin and epigallo-catechin 3-gallate in ulcerative colitis treatment","volume":"70","author":"Liu","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"34","key":"10.1016\/j.heliyon.2024.e37624_bib94","doi-asserted-by":"crossref","first-page":"40228","DOI":"10.1021\/acsami.3c07582","article-title":"Cyclodextrin-coordinated liposome-in-gel for transcutaneous quercetin delivery for psoriasis treatment","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37624_bib95","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1021\/acs.molpharmaceut.3c00729","article-title":"Development of a deep eutectic solvent-assisted kaempferol hydrogel: a promising therapeutic approach for psoriasis-like skin inflammation","volume":"20","author":"Su","year":"2023","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37624_bib96","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s13346-023-01418-4","article-title":"Preparation of luteolin loaded nanostructured lipid carrier based gel and effect on psoriasis of mice","volume":"14","author":"Xu","year":"2024","journal-title":"Drug delivery and translational research"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e37624_bib97","first-page":"124","article-title":"Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk","volume":"574","author":"Rietjens","year":"2005","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700447","article-title":"Safety aspects of the use of quercetin as a dietary supplement","volume":"62","author":"Andres","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37624_bib99","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/ptr.6063","article-title":"Toxicological effects of Camellia sinensis (green tea): a review","volume":"32","author":"Bedrood","year":"2018","journal-title":"Phytother Res. : PTR"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37624_bib100","first-page":"1892","article-title":"Acute liver failure induced by green tea extracts: case report and review of the literature, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver","volume":"12","author":"Molinari","year":"2006","journal-title":"Transplantation Society"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37624_bib101","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/toxsci\/kfh001","article-title":"Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss-Webster mouse","volume":"76","author":"Goodin","year":"2003","journal-title":"Toxicol. Sci. : an official journal of the Society of Toxicology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37624_bib102","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fct.2005.11.003","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food Chem. Toxicol. : an international journal published for the British Industrial Biological Research Association"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib103","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.fct.2009.10.030","article-title":"Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice","volume":"48","author":"Lambert","year":"2010","journal-title":"Food Chem. Toxicol. : an international journal published for the British Industrial Biological Research Association"},{"key":"10.1016\/j.heliyon.2024.e37624_bib104","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.toxrep.2016.03.001","article-title":"Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia","volume":"3","author":"Ramachandran","year":"2016","journal-title":"Toxicol Rep"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37624_bib105","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/tx050151l","article-title":"Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice","volume":"18","author":"Sang","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e37624_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1387665","article-title":"Hepatoprotective effect of kaempferol: a review of the dietary sources, bioavailability, mechanisms of action, and safety","volume":"2023","author":"Alkandahri","year":"2023","journal-title":"Advances in pharmacological and pharmaceutical sciences"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37624_bib107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1520-6866(1996)16:4<229::AID-TCM4>3.0.CO;2-K","article-title":"Mutagenicity of kaempferol in V79 cells: the role of cytochromes P450","volume":"16","author":"Silva","year":"1996","journal-title":"Teratog. Carcinog. Mutagen."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37624_bib108","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/mutage\/12.5.383","article-title":"Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol","volume":"12","author":"Silva","year":"1997","journal-title":"Mutagenesis"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37624_bib109","doi-asserted-by":"crossref","DOI":"10.4103\/ds.DS-D-22-00154","article-title":"Using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: a quick tutorial","volume":"41","author":"Chi","year":"2023","journal-title":"Dermatol. Sin."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024136559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024136559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:39:24Z","timestamp":1790714364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024136559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":109,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024136559"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37624","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring shared mechanisms between ulcerative colitis and psoriasis and predicting therapeutic natural compounds through bioinformatics and molecular docking","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37624"}}